NEW CannMed Coffee Talk, we discuss Investigating Terpenes for Chronic Pain Management! Dr. John Streicher is a Professor in the Department of Pharmacology in the College of Medicine at the University of Arizona. He has built a long-term research program focused on finding improved treatments for pain. This has encompassed multiple approaches over the years, including testing cannabinoid and non-cannabinoid constituents of Cannabis sativa, identifying new ways to target opioid receptor signaling, and identifying new receptor targets in the body for pain relief. His lab works on both the basic science knowledge of how these systems work and also works to create new drugs for human therapy. Listen Now: https://hubs.li/Q02NFBDk0 Our conversation covers: ⦾ The basics of terpenes. What they are and their role in cannabis ⦾ The cannabimimetic effects of terpenes and their synergistic effects with cannabinoids ⦾ What levels of terpenes are needed to get a therapeutic effect ⦾ A recent study showing terpenes can relieve chronic neuropathic pain ⦾ Combining terpenes with other drugs, such as opioids, to get better pain relief at lower doses ⦾ Which terpenes provide the best pain relief
Medicinal Genomics
Biotechnology Research
Beverly, MA 4,084 followers
Grow CLEAN. Grow FAST. Grow SMART.
Über uns
Medicinal Genomics is a life sciences company that distributes genetics-based platforms for quality and safety testing of legal cannabis. In addition to our testing platform, we provide services enabling legal cannabis cultivators and distributors to genetically identify cannabis strains so that the medical community can track those cannabis products that provide the maximum patient benefit and product reliability. The MGC Strain ID solution also enables growers to generate the foundational information for documenting and publishing their Intellectual Property for strains they develop. MGC was founded by Kevin McKernan, a world renowned leader in DNA sequencing technology, pioneering researcher and thought leader in cannabis genetics. MGC was the first company to sequence the cannabis genome and has subsequently sequenced hundreds of different cannabis strain genomes. This groundbreaking work has allowed MGC to provide the science for cannabis identification and safety in ways that profoundly enhance the scientific validation of the healing powers of this natural medicine.
- Website
-
https://medicinalgenomics.com
External link for Medicinal Genomics
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 11-50 Mitarbeiter
- Hauptsitz
- Beverly, MA
- Typ
- In Privatbesitz
- Gegründet
- 2011
- Spezialitäten
- Genetic based safety testing for Cannabis and Cannabis Strain ID & Certification using genetic testing
Standorte
-
Primäre
100 Cummings Center
Suite 406L
Beverly, MA 01915, US
Employees at Medicinal Genomics
Aktualisierungen
-
Registration is Open! The CannMed 25 Innovation and Investment Summit will be held from June 17-20, 2025 at the Wyndham Grand Rio Mar Beach & Golf Resort in Rio Grande, Puerto Rico. Don’t miss this opportunity to secure your spot at the industry event of the year! Take Advantage of Early Bird Pricing, view ticket packages: https://hubs.li/Q02NssTV0
-
-
To show you how easy in-house HLVd testing can be, we invite growers to bring samples to our craft table at Hall of Flowers this September! Watch as we use the BMS Myra Liquid Handler, Mic qPCR, and PathoSEEK qPCR Detection Assays to screen your samples for HLVd and get results in less than 90 minutes! Sign up at https://hubs.li/Q02MNzJB0 Hall of Flowers
-
-
Public data is critical to understanding the Cannabis testing market.
Cannabis/Aspergillus failure rate across labs in Michigan. The failure rate across the state is 3.88%. Can you identify the lab that was hit with an Aspergillus recall? https://lnkd.in/eKwUbYVE
-
-
Medicinal Genomics reposted this
We built a qPCR assay to avoid the very type of issue. The test targets P.cubensis in one channel, wood lovers in another channel and Aminita genus in a 3rd channel. Producers shouldn’t be confusing these mushrooms but here we are. https://lnkd.in/d3xK4yEp
-
-
NEW CannMed Coffee Talk, we discuss Preserving Cannabis Beverage Potency! Dr. Harold Han is Chief Science Officer and co-founder of Vertosa, and the pioneer in water compatible cannabinoid ingredients for infused products. Harold designed the industrial leading cannabis emulsions that are widely applied in the cannabis beverage brands. Harold holds 16 patents in emulsion applications, and prior to founding Vertosa, he led a team that developed the emulsification oil for Bio Rad’s Digital Droplet PCR system. Listen Now: https://hubs.li/Q02M2-Vb0 Our conversation covers: ⦾ The difference between cannabis beverages and alcoholic beverages ⦾ What happens when cannabinoids oxidize ⦾ How to put THC into water-based products using physical and chemical processes ⦾ How every aspect of the supply chain can lead to potency loss in cannabis beverages ⦾ Which beverage ingredients hasten potency loss ⦾ How packaging conditions can affect scalping and oxidation rates
-
The strain name game is still rampant in the current cannabis market, with some strains being renamed to capitalize on hype. In the latest Cannabis Equipment News podcast, Kristian Andreassen explains why Conception Nurseries has partnered with Medicinal Genomics to fingerprint each strain they sell to prove their authenticity. https://lnkd.in/ewiKwgZ3 #cannabisgenetics #cannabisgenomics #sequencing
Kristian Andreassen: Breeders Are Still Getting Ripped Off
https://www.youtube.com/
-
In the increasingly competitive cannabis industry, innovative commercial cultivators who adopt emerging technologies and methodologies will succeed. In our latest blog, we explore how commercial cannabis cultivators are using qPCR testing in their operations. https://hubs.li/Q02L9DSd0 #microbial #cultivation #agricultural #tested #keepingweedclean
-
-
NEW CannMed Coffee Talk, we discuss Treating Restless Leg Syndrome with Cannabis! At CannMed 24, Dr. Deb Kimless presented a poster that shared data from an open label clinical trial investigated using a cannabinoid-enhanced topical cream for alieviating Restless Leg Syndrome. RLS is condition that affects up to 10% of the US population, including Deb. She found relief using a CBDA-based topical cream and is working with the product manufactuer to conduct clinical trials that demonstrate its effectiveness. Listen Now: https://hubs.li/Q02KhL2Y0 Our conversation covers: - The symptoms of RLS and possible causes - Deb’s own struggles with RLS - Why many conventional and pharmaeutical treatments of RLS fall short - Why CBDA appears to be effective at alleviating RLS symptoms - Why a transdermal approach is better than ingesting or inhaling cannabinoids - Results from the open lable clincal trial including some remarkable success stories
-
MaGiC Lysis is an easy, streamlined DNA isolation method that replaces the bead-based SenSATIVAx® DNA Purification process. With MaGiC Lysis, you can prep both flower and infused products in half the steps and a third of the time. Learn more https://hubs.li/Q02KhNXB0